Company profile for RedHill Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company primarily focused on development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. RedHill’s pipeline includes several drug candidates in advanced clinical development stages addressing clear medical needs and aiming to relieve suffering and save lives. RedHill’s drugs are ...
RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company primarily focused on development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. RedHill’s pipeline includes several drug candidates in advanced clinical development stages addressing clear medical needs and aiming to relieve suffering and save lives. RedHill’s drugs are largely de-risked and are potentially of lower cost and faster to market than new chemical entities under development. RedHill’s products are based on several technology platforms.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
RedHill Biopharma Ltd. (Israel Office) 21 Ha’arba’a St., Tel-Aviv 6473921
Telephone
Telephone
+972-(0)3-541-3131
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/redhill-biopharma-successfully-regains-compliance-with-nasdaq-stockholders-equity-requirement-302629014.html

PR NEWSWIRE
01 Dec 2025

https://www.indianpharmapost.com/biopharma/redhill-secures-final-105m-court-judgment-for-enforcement-18162

INDPHARMAPOST
06 Nov 2025

https://www.prnewswire.com/news-releases/redhill-announces-10-5-million-new-york-supreme-court-judgment-win-now-final-for-enforcement-302604051.html

PR NEWSWIRE
04 Nov 2025

https://www.prnewswire.com/news-releases/redhills-talicia-secures-4-million-strategic-investment-and-us-co-commercialization-partnership-deal-302588926.html

PR NEWSWIRE
20 Oct 2025

https://www.indianpharmapost.com/news/redhill-biopharma-inks-18-million-middle-east-licensing-deal-for-talicia-17961

INDPHARMAPOST
08 Oct 2025

https://www.prnewswire.com/news-releases/redhill-wins-new-york-supreme-court-appeal-upholding-10-million-summary-judgment-against-kukbo-302569391.html

PR NEWSWIRE
29 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty